Insights On Downstream Manufacturing
-
6 Questions To Ask Your Fluid Management Component Supplier
12/19/2023
To ensure you receive the best and safest single-use components, evaluate your fluid management supplier by asking these six questions.
-
What’s Next For mRNA Research?
12/19/2023
mRNA-based therapeutics promise advanced treatments and vaccines, but commercial production remains challenging. Two experts share insights on current trends, manufacturing nuances, and how to streamline mRNA drug development.
-
Optimization-By-Design - A Critical Factor In Viral Vector Scale Up
12/14/2023
Learn how leveraging the expertise and capabilities of an experienced partner is a key factor in optimizing AAV processes using Design of Experiment (DoE), thereby reducing variability and risk.
-
Cost Efficient Manufacturing Of Purer AAV Gene Therapy Vectors
12/13/2023
Review a comparison of the cation exchange and affinity column for the first column step, and learn how the new CIMmultus High Reproducibility (HR) line columns are used for the polishing step.
-
Vial Breakage During Lyophilization: Root Causes And Mitigation
12/12/2023
Learn how controlling freezing rates, using specialized vials, and employing optimized stoppering techniques can reduce the risk of vial breakage during lyophilization and ensure high product quality.
-
Is Mannitol Hemihydrate Detrimental To Protein Stability?
12/8/2023
Maintaining an amorphous excipient matrix is crucial for protein stability. Learn about the importance of storage conditions in managing mannitol hemihydrate dehydration and ensuring protein stability.
-
Upstream To Downstream: A Comprehensive Approach To AAV Production
12/7/2023
How can you face the challenges of AAV production, scale up your AAV manufacturing effectively, and enhance the recovery and purity in your downstream processing.
-
Safer And Faster Conjugation And Purification Of ADCs At 1-20 L Scale
12/5/2023
Explore data demonstrating the successful engineering of a single-use tangential flow filtration system designed to meet the specific requirements of ADC processes.
-
Paths To mRNA Degradation, And How To Mitigate Them
12/5/2023
What causes mRNA degradation, how do you mitigate it, and what critical quality attributes are we putting in place to measure and monitor it? In this segment, Omega Therapeutics Executive Director, Process Development and Analytical Sciences Jeff Atkinson, Ph.D. addresses audience questions on the topic.
-
Advanced Tubing Retainers: Pharma+
11/30/2023
Designed to secure tubing over hose barbs effortlessly, Pharma+ retainers feature a revolutionary lead-in ramp ensuring complete 360° compression to prevent leaks.